AbbVie and Abbott-backed biotechnology developer AuraSense closed the $13.6m first tranche of the round in June last year.

G1 Therapeutics has completed a MedImmune-backed series B round to fund development of its drug protecting bone marrow in cancer patients.

Chapel Hill spin-out G1 Therapeutics lands $33m series B for less toxic oncology treatments.

StartHealth will invest an initial $1.6m in startups developing healthcare technology that can benefit lower income patients.

Lysosomal has raised $20m in a round backed by pharmaceutical firms Roche, Eli Lilly and Sanofi, all of which also contributed to its $4.8m seed round.

Contract research company SNBL has backed an $18m series A round for Wave Life Sciences, which focuses on engineering precise molecular structures for drug development.

Contract research company SNBL has backed an $18m series A round for Wave Life Sciences, which focuses on engineering precise molecular structures for drug development.